James Bender

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

Surasak Phuphanich, Christopher J. Wheeler, Jeremy Rudnick et al. · Cancer Immunology Immunotherapy · 2012 · 383 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

Christina Chu, Jean Boyer, Daniel S. Schullery et al. · Cancer Immunology Immunotherapy · 2011 · 116 citations · Full text

Medicine, Immunology, Oncology +17

Phenotypic Analysis and Characterization of CD34+ Cells from Normal Human Bone Marrow, Cord Blood, Peripheral Blood, and Mobilized Peripheral Blood from Patients Undergoing Autologous Stem Cell Transplantation

James Bender, K Unverzagt, Donald E. Walker et al. · Clinical Immunology and Immunopathology · 1994 · 113 citations

Medicine, Cell Biology, Hematology +17

Vaccination of Metastatic Colorectal Cancer Patients With Matured Dendritic Cells Loaded With Multiple Major Histocompatibility Complex Class I Peptides

Brian D. Kavanagh, Andrew H. Ko, Alan P. Venook et al. · Journal of Immunotherapy · 2007 · 103 citations

Medicine, Immunology, Oncology +17

Induction of Immune Responses and Clinical Efficacy in a Phase II Trial of IDM-2101, a 10-Epitope Cytotoxic T-Lymphocyte Vaccine, in Metastatic Non–Small-Cell Lung Cancer

Minal Barve, James Bender, Neil Senzer et al. · Journal of Clinical Oncology · 2008 · 99 citations

Medicine, Immunology, Oncology +17